| PRECLINICAL | evidence | Thymosin beta 4 is associated with RUNX2 expression through the Smad and Akt signaling pathways in mouse dental epithelial cells. | Thymosin beta 4 | — | 2015-05-01 |
| PRECLINICAL | evidence | H2O2 Exposure Affects Myotube Stiffness and Actin Filament Polymerization. | Thymosin beta 4 | — | 2015-05-01 |
| PRECLINICAL | evidence | Two functionally distinct sources of actin monomers supply the leading edge of lamellipodia. | Tbeta4 | — | 2015-04-21 |
| PRECLINICAL | evidence | Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4. | Tbeta4 | — | 2015-04-15 |
| PRECLINICAL | evidence | Effect of thymosin beta 4 in the presence of up-regulation of the insulin-like growth factor-1 signaling pathway on high-glucose-exposed vascular endothelial cells. | Tbeta4 | Growth hormone axis · preclinical | 2015-02-05 |
| PRECLINICAL | evidence | The role of thymosin-beta4 in kidney disease. | Thymosin beta 4 | — | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye. | Tbeta4 | Wound healing | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin beta4: multiple functions in protection, repair and regeneration of the mammalian heart. | Tbeta4 | Lipid & cardiovascular markers | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin Beta-4 Induces Mouse Hair Growth. | Tbeta4 | — | 2015-01-01 |
| PRECLINICAL | evidence | Effects of thymosin beta4 and its N-terminal fragment Ac-SDKP on TGF-beta-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis. | Tbeta4 | — | 2015-01-01 |
| PRECLINICAL | evidence | Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver. | Tbeta4 | Liver health · preclinical | 2015-01-01 |
| PRECLINICAL | evidence | High-resolution mass spectrometry for thymosins detection and characterization. | Tbeta4 | — | 2015-01-01 |
| PRECLINICAL | evidence | In vitro models for metabolic studies of small peptide hormones in sport drug testing. | TB 500 | — | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin Beta-4, Actin-Sequestering Protein Regulates Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Nitric Oxide Production in HeLa Cervical Cancer Cells. | Tbeta4 | — | 2015-01-01 |
| PRECLINICAL | evidence | Advances in the basic and clinical applications of thymosin beta4. | Tbeta4 | Wound healing | 2015-01-01 |
| PRECLINICAL | evidence | Correction: Thymosin beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. | Thymosin beta 4 | — | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin beta 4 may translocate from the cytoplasm in to the nucleus in HepG2 cells following serum starvation. An ultrastructural study. | Tbeta4 | — | 2015-01-01 |
| PRECLINICAL | evidence | N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain. | Tbeta4 | Lipid & cardiovascular markers | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE) model. | RGN-259 | — | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin-beta4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway. | Tbeta4 | — | 2015-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 as a restorative/regenerative therapy for neurological injury and neurodegenerative diseases. | Tbeta4 | Neuroprotection | 2015-01-01 |
| PRECLINICAL | evidence | Identification of PDGF-BB binding to thymosin beta4 by chemical cross-linking. | Tbeta4 | Liver health · preclinical | 2015-01-01 |
| PRECLINICAL | evidence | Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4. | Tbeta4 | Longevity & cellular aging | 2015-01-01 |
| PRECLINICAL | evidence | Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions. | TB 500 | — | 2014-12-01 |
| PRECLINICAL | evidence | Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. | TB 500 | — | 2014-12-01 |
| PRECLINICAL | evidence | Thymosin beta 4 improves dermal burn wound healing via downregulation of receptor of advanced glycation end products in db/db mice. | Tbeta4 | — | 2014-12-01 |
| PRECLINICAL | evidence | Effect of butyrate on immune response of a chicken macrophage cell line. | Tbeta4 | Inflammation | 2014-11-15 |
| PRECLINICAL | evidence | [Association of intracellular proteinase activities with the content of locomotor proteins in tissues of primary tumors and metastasis in ovarian cancer]. | Thymosin β4 | — | 2014-11-01 |
| PRECLINICAL | evidence | Thymosin beta-4 knockdown in IEC-6 normal intestinal epithelial cells induces DNA re-replication via downregulating Emi1. | Tbeta4 | — | 2014-11-01 |
| PRECLINICAL | evidence | Identification of black market products and potential doping agents in Germany 2010-2013. | Thymosin β4 | — | 2014-11-01 |
| PRECLINICAL | evidence | Structural basis of thymosin-beta4/profilin exchange leading to actin filament polymerization. | Tbeta4 | — | 2014-10-28 |
| PRECLINICAL | evidence | Thymosin beta4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/beta-catenin signaling pathway. | Tbeta4 | preclinical | 2014-09-26 |
| PRECLINICAL | evidence | In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA. | Tbeta4 | — | 2014-09-01 |
| PRECLINICAL | evidence | Novel modulators of hepatosteatosis, inflammation and fibrogenesis. | Tbeta4 | — | 2014-09-01 |
| PRECLINICAL | evidence | Thymosin beta4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway. | Tbeta4 | Inflammation | 2014-07-11 |
| PRECLINICAL | evidence | Thymosinbeta4: a novel assessed biomarker of the prognosis of acute-on-chronic liver failure patient? | Tbeta4 | — | 2014-06-01 |
| PRECLINICAL | evidence | New molecular medicine-based scar management strategies. | Thymosin β4 | — | 2014-06-01 |
| PRECLINICAL | evidence | Over-expression of thymosin beta4 in granulomatous lung tissue with active pulmonary tuberculosis. | Tbeta4 | — | 2014-05-01 |
| PRECLINICAL | evidence | The anti-promyelocytic leukemia mode of action of two endophytic secondary metabolites unveiled by a proteomic approach. | Thymosin beta 4 | Longevity & cellular aging · preclinical | 2014-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 regulates cardiac valve formation via endothelial-mesenchymal transformation in zebrafish embryos. | Thymosin beta 4 | — | 2014-04-01 |
| PRECLINICAL | evidence | Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry. | Thymosin β4 | — | 2014-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 regulates cardiac valve formation via endothelial-mesenchymal transformation in zebrafish embryos. | TB4 | — | 2014-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 coated nanofiber scaffolds for the repair of damaged cardiac tissue. | Thymosin beta 4 | — | 2014-03-24 |
| PRECLINICAL | evidence | Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma. | Tbeta4 | — | 2014-03-11 |
| PRECLINICAL | evidence | In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-beta4 as markers of malignant intraductal pancreatic mucinous neoplasms. | Thymosin beta 4 | — | 2014-03-01 |
| PRECLINICAL | evidence | Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma. | Thymosin beta 4 | — | 2014-02-01 |
| PRECLINICAL | evidence | Thymosin beta4 inhibits ADF/cofilin stimulated F-actin cycling and hela cell migration: reversal by active Arp2/3 complex. | Tbeta4 | — | 2014-02-01 |
| PRECLINICAL | evidence | Thymosin beta4 was upregulated in recurred colorectal cancers. | Thymosin beta 4 | — | 2014-02-01 |
| PRECLINICAL | evidence | Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. | Tbeta4 | — | 2014-01-01 |
| PRECLINICAL | evidence | The actin-sequestering protein thymosin beta-4 is a novel target of hypoxia-inducible nitric oxide and HIF-1alpha regulation. | Tbeta4 | — | 2014-01-01 |